How does CKD affect HbA1c? - PubMed
HOW DOES CHRONIC KIDNEY DISEASE AFFECT HBA1C?: A number of factors determine HbA1c other than the level of glucose exposure alone. In an subset analysis of the …
We recommend using hemoglobin A1c (HbA1c) to monitor glycemic control in patients with diabetes and CKD (1C). We recommend an individualized HbA1c target ranging from <6.5% …
KDIGO recommendations for the evaluation of glycemic control in ...
2021年12月10日 · The guideline states “Hemoglobin A1c (HbA1c) is recommended to monitor glycemic control in patients with diabetes and CKD” 1(pS23) and “Accuracy and precision of …
Diabetes management in chronic kidney disease: a consensus …
2022年6月17日 · People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. …
Chronic Kidney Disease in Diabetes: Guidelines from KDIGO
2021年6月1日 · People with diabetes and CKD have high risks of CKD progression, cardiovascular disease (CVD), and mortality, which can be reduced with a comprehensive …
Assessment of glycemia in chronic kidney disease - BMC Medicine
2022年4月13日 · In this review, focused on patients with chronic kidney disease (CKD), we will discuss the unique aspects of glycemic disarray in kidney disease and summarize the …
Effect of chronic kidney disease on A1C in individuals being
Objective: Glycated haemoglobin (A1C) has been recommended for the diagnosis of type 2 diabetes mellitus. Chronic kidney disease (CKD) is reported to increase A1C. The prevalence …
Impact of haemoglobin A1c trajectories on chronic kidney disease ...
Results: We identified four HbA1c trajectories: 'near-optimal stable' (49.1%), 'moderate stable' (37.9%), 'moderate-increasing' (6.0%) and 'high-decreasing' (7.0%). Over a median follow-up …
Variability in HbA1c and the risk of major clinical outcomes in …
4 天之前 · Higher HbA1c variability predicts worse cardiovascular and renal outcomes in T2D patients with CKD, independent of mean HbA1c levels. These findings underscore the …
粥样硬化风险的社区研究亚组分析中，纳入了941名合并不同程度慢性肾脏疾病（chronic kidney disease，CKD）以及724名没有合并CKD的糖尿病患者，他们的平均年龄为80岁，Jung 等2 …